Search
for
Sort by
Research 121–150 of 1000+
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- Metabolic dysfunction in female mice with disruption of 5α-reductase 1
- Distinct Conditions Support a Novel Classification for Bradykinin-Mediated Angio-Oedema
- The Charnoly body as a universal biomarker of cell injury
- Analysis of the function of ADAM17 in iRhom2 curly-bare and tylosis with esophageal cancer mutant mice
- Compendium of polycystic ovarian syndrome and its relevance in glycation and diabetes
- The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics
- Morphological changes in the skin in a rat model of stress-induced alopecia and their correction with nutrients
- From basic biology to engineered therapies: the keratinocyte stem cell playbook
- Ca <sup>2+</sup> -mediated protein citrullination regulates proliferation in the regenerating and malignant CNS
- Dermal papilla cells-conditioned medium attenuates oxidative stress-induced senescence via ferroptosis inhibition
- Overexpression of HE4/WFDC2 gene in mice leads to keratitis and corneal opacity
- Valence-engineered catalysis-selectivity regulation of molybdenum oxide nanozyme for acute kidney injury therapy and post-cure assessment
- Cloning, computational analysis and expression profiling of steroid 5 alpha-reductase 1 (SRD5A1) gene during reproductive phases and ovatide stimulation in endangered catfish, Clarias magur
- Chitosan stimulates root hair callose deposition and inhibits root hair growth
- Modeling the pharmacodynamics of nandrolone doping drug and implications for anti‐doping testing
- Untersuchungen der Fremdstoffbindung in permanenten Keratinozyten- und Melanozyten-Zelllinien sowie die Eignung von Primärkulturen aus humanen Haarfollikeln zur In-vitro-Messung der Fremdstoffaufnahme im Haar
- Congenital Adrenal Hyperplasia
- Insulin Resistance and Skin Diseases
- Mutant laboratory mice with abnormalities in hair follicle morphogenesis, cycling, and/or structure: An update
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- Pediatric Endocrine-Disrupting Chemical Exposure Produces Irreversible Organizational Injury: Biomarker Evidence Necessitating a Precautionary Public Health Framework
- ‘’Brown adipose tissue in the form of innovative approach for polycystic ovary syndrome treatment-still long time to reach clinical arena: a narrative review’’
- Abstracts Pt.30
- Is COVID-19 Gender-sensitive?
- The expression of the gene <i>asebia</i> in the laboratory mouse: 3. Sebaceous glands
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease
- Modulating the stem cell niche for tissue regeneration
- Developmental origin of polycystic ovary syndrome - a hypothesis